• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Survival Prediction After Neurosurgical Resection of Brain Metastases: A Machine Learning Approach.脑转移瘤神经外科切除术后的生存预测:一种机器学习方法。
Neurosurgery. 2022 Sep 1;91(3):381-388. doi: 10.1227/neu.0000000000002037. Epub 2022 May 26.
2
Machine learning approaches for prediction of early death among lung cancer patients with bone metastases using routine clinical characteristics: An analysis of 19,887 patients.利用常规临床特征预测肺癌伴骨转移患者早期死亡的机器学习方法:对 19887 例患者的分析。
Front Public Health. 2022 Oct 6;10:1019168. doi: 10.3389/fpubh.2022.1019168. eCollection 2022.
3
International Validation of the SORG Machine-learning Algorithm for Predicting the Survival of Patients with Extremity Metastases Undergoing Surgical Treatment.国际验证 SORG 机器学习算法在预测接受手术治疗的肢体转移患者生存情况的应用。
Clin Orthop Relat Res. 2022 Feb 1;480(2):367-378. doi: 10.1097/CORR.0000000000001969.
4
External Validation of PATHFx Version 3.0 in Patients Treated Surgically and Nonsurgically for Symptomatic Skeletal Metastases.手术和非手术治疗有症状性骨转移患者中 PATHFx 版本 3.0 的外部验证。
Clin Orthop Relat Res. 2020 Apr;478(4):808-818. doi: 10.1097/CORR.0000000000001081.
5
A machine learning-based prediction model for in-hospital mortality among critically ill patients with hip fracture: An internal and external validated study.基于机器学习的危重症髋部骨折患者院内死亡率预测模型:内部和外部验证研究。
Injury. 2023 Feb;54(2):636-644. doi: 10.1016/j.injury.2022.11.031. Epub 2022 Nov 12.
6
Development of a web-based calculator to predict three-month mortality among patients with bone metastases from cancer of unknown primary: An internally and externally validated study using machine-learning techniques.基于网络的计算器用于预测原发灶不明癌症骨转移患者三个月死亡率的开发:一项使用机器学习技术进行内部和外部验证的研究
Front Oncol. 2022 Dec 7;12:1095059. doi: 10.3389/fonc.2022.1095059. eCollection 2022.
7
Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers.机器学习算法在(放化疗)治疗结果预测中的应用:分类器的实证比较。
Med Phys. 2018 Jul;45(7):3449-3459. doi: 10.1002/mp.12967. Epub 2018 Jun 13.
8
Can Predictive Modeling Tools Identify Patients at High Risk of Prolonged Opioid Use After ACL Reconstruction?预测模型工具能否识别 ACL 重建术后阿片类药物使用时间延长的高风险患者?
Clin Orthop Relat Res. 2020 Jul;478(7):0-1618. doi: 10.1097/CORR.0000000000001251.
9
Can Machine-learning Algorithms Predict Early Revision TKA in the Danish Knee Arthroplasty Registry?机器学习算法能否预测丹麦膝关节置换登记处的早期翻修 TKA?
Clin Orthop Relat Res. 2020 Sep;478(9):2088-2101. doi: 10.1097/CORR.0000000000001343.
10
Predicting leptomeningeal disease spread after resection of brain metastases using machine learning.使用机器学习预测脑转移瘤切除术后软脑膜疾病的扩散
J Neurosurg. 2022 Oct 21;138(6):1561-1569. doi: 10.3171/2022.8.JNS22744. Print 2023 Jun 1.

引用本文的文献

1
Implementation and Updating of Clinical Prediction Models: A Systematic Review.临床预测模型的实施与更新:一项系统综述
Mayo Clin Proc Digit Health. 2025 May 23;3(3):100228. doi: 10.1016/j.mcpdig.2025.100228. eCollection 2025 Sep.
2
Prognostic Factors in Postoperative Brain Metastases Derive From Non-small Cell Lung Cancer: A Retrospective Analysis.非小细胞肺癌术后脑转移的预后因素:一项回顾性分析
Clin Med Insights Oncol. 2024 Dec 11;18:11795549241304532. doi: 10.1177/11795549241304532. eCollection 2024.
3
Development and validation of a prediction model for hypoproteinemia after traumatic spinal cord injury: A multicenter retrospective clinical study.创伤性脊髓损伤后低蛋白血症预测模型的建立与验证:一项多中心回顾性临床研究。
Medicine (Baltimore). 2024 Jun 21;103(25):e38081. doi: 10.1097/MD.0000000000038081.
4
Artificial Intelligence in Neurosurgery: A State-of-the-Art Review from Past to Future.神经外科中的人工智能:从过去到未来的最新综述
Diagnostics (Basel). 2023 Jul 20;13(14):2429. doi: 10.3390/diagnostics13142429.

脑转移瘤神经外科切除术后的生存预测:一种机器学习方法。

Survival Prediction After Neurosurgical Resection of Brain Metastases: A Machine Learning Approach.

机构信息

Computational Neuroscience Outcomes Center, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Departments of Neurosurgery, Haaglanden Medical Center and Leiden University Medical Center, Leiden University, Leiden, The Netherlands.

出版信息

Neurosurgery. 2022 Sep 1;91(3):381-388. doi: 10.1227/neu.0000000000002037. Epub 2022 May 26.

DOI:10.1227/neu.0000000000002037
PMID:35608378
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10553019/
Abstract

BACKGROUND

Current prognostic models for brain metastases (BMs) have been constructed and validated almost entirely with data from patients receiving up-front radiotherapy, leaving uncertainty about surgical patients.

OBJECTIVE

To build and validate a model predicting 6-month survival after BM resection using different machine learning algorithms.

METHODS

An institutional database of 1062 patients who underwent resection for BM was split into an 80:20 training and testing set. Seven different machine learning algorithms were trained and assessed for performance; an established prognostic model for patients with BM undergoing radiotherapy, the diagnosis-specific graded prognostic assessment, was also evaluated. Model performance was assessed using area under the curve (AUC) and calibration.

RESULTS

The logistic regression showed the best performance with an AUC of 0.71 in the hold-out test set, a calibration slope of 0.76, and a calibration intercept of 0.03. The diagnosis-specific graded prognostic assessment had an AUC of 0.66. Patients were stratified into regular-risk, high-risk and very high-risk groups for death at 6 months; these strata strongly predicted both 6-month and longitudinal overall survival ( P < .0005). The model was implemented into a web application that can be accessed through http://brainmets.morethanml.com .

CONCLUSION

We developed and internally validated a prediction model that accurately predicts 6-month survival after neurosurgical resection for BM and allows for meaningful risk stratification. Future efforts should focus on external validation of our model.

摘要

背景

目前的脑转移瘤(BMs)预后模型几乎完全是基于接受 upfront 放疗的患者数据构建和验证的,因此对于接受手术治疗的患者存在不确定性。

目的

使用不同的机器学习算法构建和验证预测 BM 切除术后 6 个月生存的模型。

方法

利用 1062 例接受 BM 切除术患者的机构数据库,将其分为 80:20 的训练和测试集。使用七种不同的机器学习算法进行训练和评估性能;还评估了用于接受放疗的 BM 患者的既定预后模型,即诊断特异性分级预后评估。使用曲线下面积(AUC)和校准来评估模型性能。

结果

逻辑回归在验证测试集中表现最佳,AUC 为 0.71,校准斜率为 0.76,校准截距为 0.03。诊断特异性分级预后评估的 AUC 为 0.66。患者被分为 6 个月死亡的常规风险、高风险和极高风险组;这些分层强烈预测了 6 个月和纵向总生存(P <.0005)。该模型已实现为一个网络应用程序,可以通过 http://brainmets.morethanml.com 访问。

结论

我们开发并内部验证了一种预测模型,该模型可准确预测 BM 神经外科切除术后 6 个月的生存情况,并可进行有意义的风险分层。未来的工作应集中在对我们模型的外部验证上。